ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Photodynamic amplified immune checkpoint-blockade therapy of self-delivery bioregulator via epigenetic reprogramming

Zhao, Linping; Huang, Chuyu; Zheng, Rongrong; Rao, Xiaona; Kong, Renjiang; Guan, Runtian; Chen, Zuxiao; Yu, Xiyong; Cheng, Hong*; Li, Shiying*广州医学院; 南方医科大学
Chemical Engineering Journal2023-2-1DOI: 10.1016/j.cej.2022.139729
3被引15阅读
引用收藏
分享

摘要

Photodynamic therapy (PDT) and immunotherapy have unique advantages for primary and metastatic tumor treatment. However, immunosuppressive tumor microenvironment (ITM) causes low immune responses and various degrees of therapeutic resistance. In this work, a self-delivery bioregulator (C-Moc) is developed for photodynamic amplified immune checkpoint-blockade (ICB) therapy by epigenetic reprogramming. To be spe-cific, carrier-free C-Moc is prepared by the self-assembly of chlorine e6 (Ce6) and mocetinostat (Moc) in the presence of DSPE-PEG2000 through electrostatic and hydrophobic interactions. Of note, nanosized C-Moc has an improved stability, cellular uptake and pharmacokinetics behaviors. Intravenously injected C-Moc prefers to accumulate at tumor site and then penetrate into tumor tissues upon light irradiation. Meanwhile, the initiated PDT would kill tumor cells for primary tumor inhibition and also induce immunogenic cell death (ICD) to activate antitumor immunity. More importantly, C-Moc is able to increase the expressions of MHC-I and PD-L1 to regulate ITM by epigenetic reprogramming, which would promote the recognition of immune system to MHC-I overexpressed tumor cells and enhance the ICB therapy of alpha-PD-L1. This photodynamic amplified ICB therapy of C-Moc shows a great superiority over the single treatment on primary and distant tumor suppression.

学科与关键词

关键词
Epigenetic reprogrammingImmune checkpoint -blockadePhotodynamic therapySelf -deliveryImmunogenic cell death
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Chemical Engineering Journal
发表日期
2023-02-01
卷期
第 453 卷
页码
139729
DOI
10.1016/j.cej.2022.139729
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Guangdong Basic and Applied Basic Research Foundation [2021B1515020043, 2022B1515020095]; National Natural Science Foundation of China [52073140]; National Key R&D Program of China [2021YFD1800600]; Open Research Foundation of State Key Laboratory of Respiratory Diseases [SKLRD-OP-202204]

作者

  • Z

    Zhao, Linping (第一作者)

    guangzhou med univ

  • H

    Huang, Chuyu

    guangzhou med univ

查看全部 10 位作者收起作者
  • Z

    Zheng, Rongrong

    guangzhou med univ

  • R

    Rao, Xiaona

    guangzhou med univ

  • K

    Kong, Renjiang

  • G

    Guan, Runtian

    guangzhou med univ

  • C

    Chen, Zuxiao

    guangzhou med univ

  • Y

    Yu, Xiyong

    guangzhou med univ

  • C

    Cheng, Hong (通讯)

    southern med univ

  • L

    Li, Shiying (通讯)

    guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417